Gonadal Gatekeeper of Quasi‑Programmed Aging: A Testable Model Linking Reproductive Signals to mTORC1 Hyperfunction

Hypothesis

The quasi‑programmed view of aging posits that developmental growth pathways, especially mTORC1, remain active after maturity, driving senescence as a purposeless continuation of growth [6]. We propose that this persistence is not random but is actively restrained by a gonadal‑derived signal that conveys reproductive status to somatic tissues. When gonadal output declines after the reproductive window, the inhibitory signal wanes, mTORC1 activity rises unchecked, and quasi‑programmed aging accelerates. Thus, aging is a conditionally launched program whose trigger is the loss of gonadal feedback, not an inevitable timer.

Mechanistic Basis

• In many vertebrates, gonadal steroids (estradiol, testosterone) and peptide hormones (inhibin, activin) exert tonic suppression of hypothalamic mTORC1 via SIRT1‑dependent deacetylation of TSC2 [1].
• This suppression propagates downstream through the pituitary‑GH/IGF‑1 axis, keeping peripheral mTORC1 activity in a low‑growth mode [2].
• After reproductive senescence, circulating gonadotropins fall, reducing SIRT1 activity in the hypothalamus, disinhibiting mTORC1 and permitting the hyperfunction cascade that drives cellular senescence, impaired autophagy, and inflammaging [3].
• The quasi‑programmed phenotype therefore reflects a switch from a gonadally buffered state to a default mTOR‑driven growth state that was never selected to be turned off because selection wanes post‑reproduction [4].

Testable Predictions

1. Pharmacologic or genetic augmentation of gonadal steroid signaling in middle‑aged mammals will blunt mTORC1 activation in brain and peripheral tissues, delaying markers of quasi‑programmed aging without extending fertility.
2. Conversely, chemical castration or GnRH antagonism in young adults will precipitate early mTORC1 hyperactivity and accelerate age‑related phenotypes, mimicking the quasi‑programmed state.
3. Rescue of gonadal signaling after induced mTORC1 activation will reverse downstream aging markers (e.g., restore autophagy flux, reduce SASP) only if administered before a critical window, indicating a time‑sensitive gate.

Potential Experiments

• Model: Use inducible GnRH receptor knockout mice. Measure hypothalamic p‑S6K (mTORC1 readout), LC3‑II/I ratio, and p16^INK4a^ expression at 6, 12, and 18 months.
• Intervention: Treat cohorts with either estradiol‑releasing pellets or vehicle starting at 10 months.
• Readouts: Healthspan (grip strength, treadmill endurance), lifespan, and transcriptomic signatures of quasi‑programmed aging (hyperactive mTOR targets, suppressed autophagy genes).
• Falsification: If gonadally intact animals show no difference in mTORC1 activity or aging markers despite manipulated gonadal signaling, the hypothesis is refuted.

By linking the quasi‑programmed model to an experimentally manipulable gonadal gate, this hypothesis transforms aging from an inexorable byproduct into a conditionally launched program that can be postponed or accelerated by modulating reproductive‑axis signals.